Voya Financial Advisors’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$868K Sell
4,145
-434
-9% -$96.3K 0.09% 101
2025
Q4
$1.06M Sell
4,579
-388
-8% -$88.4K 0.1% 94
2025
Q3
$1.11M Sell
4,967
-383
-7% -$78K 0.11% 93
2025
Q2
$975K Buy
5,350
+1,326
+33% +$246K 0.1% 103
2025
Q1
$826K Sell
4,024
-1,065
-21% -$207K 0.09% 105
2024
Q4
$897K Buy
5,089
+745
+17% +$137K 0.1% 103
2024
Q3
$846K Buy
4,344
+724
+20% +$135K 0.09% 102
2024
Q2
$612K Buy
3,620
+36
+1% +$5.96K 0.07% 135
2024
Q1
$646K Sell
3,584
-571
-14% -$98.4K 0.07% 123
2023
Q4
$643K Buy
4,155
+94
+2% +$13.7K 0.08% 121
2023
Q3
$618K Sell
4,061
-137
-3% -$20.1K 0.08% 117
2023
Q2
$559K Sell
4,198
-180
-4% -$26.4K 0.07% 130
2023
Q1
$691K Sell
4,378
-52
-1% -$7.95K 0.09% 109
2022
Q4
$720K Buy
4,430
+266
+6% +$40.8K 0.09% 108
2022
Q3
$594K Buy
4,164
+48
+1% +$6.89K 0.08% 124
2022
Q2
$634K Sell
4,116
-141
-3% -$21.5K 0.08% 117
2022
Q1
$697K Sell
4,257
-1,556
-27% -$226K 0.08% 123
2021
Q4
$790K Buy
5,813
+325
+6% +$38.4K 0.09% 119
2021
Q3
$597K Buy
5,488
+249
+5% +$28.5K 0.07% 139
2021
Q2
$588K Sell
5,239
-41,897
-89% -$4.72M 0.08% 141
2021
Q1
$5.03M Buy
47,136
+29
+0.1% +$3.1K 0.2% 84
2020
Q4
$4.96M Buy
47,107
+2,349
+5% +$226K 0.21% 73
2020
Q3
$3.89M Sell
44,758
-5,836
-12% -$549K 0.19% 81
2020
Q2
$4.88M Sell
50,594
-7,429
-13% -$654K 0.26% 64
2020
Q1
$4.37M Sell
58,023
-4,082
-7% -$348K 0.24% 69
2019
Q4
$5.5M Buy
62,105
+2,973
+5% +$247K 0.27% 69
2019
Q3
$4.43M Buy
59,132
+885
+2% +$60.7K 0.24% 81
2019
Q2
$4.08M Buy
58,247
+1,922
+3% +$151K 0.22% 86
2019
Q1
$4.5M Buy
56,325
+6,017
+12% +$492K 0.26% 79
2018
Q4
$4.58M Buy
50,308
+7,385
+17% +$649K 0.31% 70
2018
Q3
$4.04M Buy
42,923
+5,245
+14% +$497K 0.24% 82
2018
Q2
$3.48M Buy
37,678
+374
+1% +$36.5K 0.23% 87
2018
Q1
$3.52M Sell
37,304
-2,678
-7% -$294K 0.23% 94
2017
Q4
$3.91M Sell
39,982
-1,466
-4% -$138K 0.25% 89
2017
Q3
$3.69M Sell
41,448
-12,984
-24% -$988K 0.25% 86
2017
Q2
$3.94M Buy
54,432
+7,508
+16% +$505K 0.28% 73
2017
Q1
$3.09M Buy
46,924
+1,361
+3% +$85.6K 0.24% 89
2016
Q4
$2.86M Buy
45,563
+1,640
+4% +$100K 0.25% 81
2016
Q3
$2.76M Buy
43,923
+3,697
+9% +$239K 0.28% 73
2016
Q2
$2.49M Buy
40,226
+8,178
+26% +$498K 0.29% 68
2016
Q1
$1.83M Buy
32,048
+4,965
+18% +$277K 0.25% 74
2015
Q4
$1.62M Buy
27,083
+7,668
+39% +$442K 0.24% 76
2015
Q3
$1.02M Sell
19,415
-3,592
-16% -$234K 0.18% 95
2015
Q2
$1.55M Buy
23,007
+154
+0.7% +$10.1K 0.27% 70
2015
Q1
$1.33M Buy
+22,853
New +$1.38M 0.26% 89

Other funds holding ABBV

Voya Financial Advisors's ABBV Position: Q1 2026 in Review

Voya Financial Advisors reduced its AbbVie (ABBV) stake by 9.5% in Q1 2026, selling an estimated $96.3K and leaving 4,145 shares worth $868K. The position accounts for 0.09% of the portfolio, ranked #101.

Voya Financial Advisors first reported a position in ABBV in Q1 2015 and has held it in 45 quarters since. The position peaked at $5.5M in Q4 2019. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Voya Financial Advisors held 4,145 shares of AbbVie worth $868K as of Q1 2026.
  • Voya Financial Advisors sold 434 AbbVie shares in Q1 2026, an estimated $96.3K.
  • AbbVie made up 0.09% of Voya Financial Advisors's portfolio in Q1 2026, its #101 holding.
  • Voya Financial Advisors first reported a position in AbbVie in Q1 2015 and has held it in 45 quarters since.
  • Voya Financial Advisors's AbbVie position peaked at $5.5M in Q4 2019.
  • 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Voya Financial Advisors's 13F filing for Q1 2026, filed 12 May 2026.